Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke

IJERPH, Free Full-Text

Tissue Plasminogen Activator–Induced Reperfusion Injury After Stroke Revisited

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Tissue Plasminogen Activator Market is estimated to be valued at US$ 2,455.4 million in 2022 and is expected to exhibit a CAGR of 5.2% over the forecast period (2020-2027).

Update on Management of Acute Ischemic Stroke in The Emergency Department

JCM, Free Full-Text

Full article: Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase

PDF) Tissue plasminogen activator for acute ischemic stroke

The Neurotoxicity of Tissue Plasminogen Activator? - Jaspreet Kaur, Zonghang Zhao, Gary M. Klein, Eng H. Lo, Alastair M. Buchan, 2004